Skip to main content

Advertisement

SpringerLink
Log in

Association of serum adiponectin level with albuminuria in chronic kidney disease patients

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Adiponectin, a peptide hormone secreted from adipocytes, exerts anti-diabetic, anti-atherogenic, and anti-inflammatory properties. We aimed to determine the relationship between serum adiponectin levels and albuminuria, and evaluate determinant factors for serum adiponectin in patients with chronic kidney disease (CKD).

Methods

In total, 1442 CKD patients were included and divided into three groups according to their albumin-to-creatinine ratios: patients with normoalbuminuria (N = 228), microalbuminuria (N = 444), and macroalbuminuria (N = 761). Serum adiponectin was specifically assayed with a commercially available enzyme-linked immunosorbent assay kit.

Results

Serum adiponectin was significantly higher in patients with macroalbuminuria than in those without macroalbuminuria (9.7 ± 6.0, 12.4 ± 9.0, and 14.9 ± 11.0 μg/mL in patients with normoalbuminuria, microalbuminuria, and macroalbuminuria, respectively). Univariate linear regression analysis showed that the serum adiponectin concentrations were correlated with age, the albumin-to-creatinine ratio, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol, whereas they were negatively correlated with body mass index, the estimated glomerular filtration rate, and serum albumin and triglyceride levels. The stepwise regression multiple analysis showed that sex; the estimated glomerular filtration rate; body mass index; total cholesterol, high-density lipoprotein cholesterol, and triglyceride levels; and logarithm of the albumin-to-creatinine ratio were independently associated with the logarithm of serum adiponectin levels (r = 0.55, p < 0.001).

Conclusion

Serum adiponectin concentrations are higher in patients with increasing albuminuria, and these levels are associated with renal insufficiency and lipid profiles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K, et al. Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med. 2012;172:1644–50.

    Article  PubMed  Google Scholar 

  2. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148:293–300.

    Article  CAS  PubMed  Google Scholar 

  3. Nakamaki S, Satoh H, Kudoh A, Hayashi Y, Hirai H, Watanabe T. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Exp Biol Med (Maywood). 2011;236:614–20.

    Article  CAS  PubMed  Google Scholar 

  4. Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol. 2007;27:1910–7.

    Article  CAS  PubMed  Google Scholar 

  5. Christou GA, Kiortsis DN. The role of adiponectin in renal physiology and development of albuminuria. J Endocrinol. 2014;221:R49–61.

    Article  CAS  PubMed  Google Scholar 

  6. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:134–41.

    Article  CAS  PubMed  Google Scholar 

  7. Oh KH, Park SK, Park HC, Chin HJ, Chae DW, Choi KH, et al. KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. BMC Nephrol. 2014;15:80.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Magkos F, Sidossis LS. Recent advances in the measurement of adiponectin isoform distribution. Curr Opin Clin Nutr Metab Care. 2007;10:571–5.

    Article  CAS  PubMed  Google Scholar 

  10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266.

    Google Scholar 

  11. Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr. 2004;23:963–74.

    Article  CAS  PubMed  Google Scholar 

  12. Stefan N, Stumvoll M. Adiponectin—its role in metabolism and beyond. Horm Metab Res. 2002;34:469–74.

    Article  CAS  PubMed  Google Scholar 

  13. Fujita H, Morii T, Koshimura J, Ishikawa M, Kato M, Miura T, et al. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy. Endocr J. 2006;53:745–52.

    Article  CAS  PubMed  Google Scholar 

  14. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem. 2003;278:9073–85.

    Article  CAS  PubMed  Google Scholar 

  15. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003;278:40352–63.

    Article  CAS  PubMed  Google Scholar 

  16. von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B, et al. Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes. 2009;58:2093–9.

    Article  Google Scholar 

  17. Cammisotto PG, Bendayan M. Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli. J Mol Histol. 2008;39:579–84.

    Article  CAS  PubMed  Google Scholar 

  18. Perri A, Vizza D, Lofaro D, Gigliotti P, Leone F, Brunelli E, et al. Adiponectin is expressed and secreted by renal tubular epithelial cells. J Nephrol. 2013;26:1049–54.

    Article  PubMed  Google Scholar 

  19. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Investig. 2008;118:1645–56.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Yu Y, Bao BJ, Fan YP, Shi L, Li SQ. Changes of adiponectin and its receptors in rats following chronic renal failure. Ren Fail. 2014;36:92–7.

    Article  CAS  PubMed  Google Scholar 

  21. Koshimura J, Fujita H, Narita T, Shimotomai T, Hosoba M, Yoshioka N, et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun. 2004;316:165–9.

    Article  CAS  PubMed  Google Scholar 

  22. Jorsal A, Petersen EH, Tarnow L, Hess G, Zdunek D, Frystyk J, et al. Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes. J Diabetes Complicat. 2013;27:604–8.

    Article  PubMed  Google Scholar 

  23. Guo X, Zhou G, Guo M, Cheung AK, Huang Y, Beddhu S. Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II. Physiol Rep. 2014;2:e00230.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Rutkowski JM, Wang ZV, Park AS, Zhang J, Zhang D, Hu MC, et al. Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol. 2013;24:268–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Rabin KR, Kamari Y, Avni I, Grossman E, Sharabi Y. Adiponectin: linking the metabolic syndrome to its cardiovascular consequences. Expert Rev Cardiovasc Ther. 2005;3:465–71.

    Article  CAS  PubMed  Google Scholar 

  26. Hashikawa-Hobara N, Chan NY, Levi R. Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart. J Pharmacol Exp Ther. 2012;340:185–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421–6.

    Article  CAS  PubMed  Google Scholar 

  28. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 1992;340:319–23.

    Article  CAS  PubMed  Google Scholar 

  29. Nishigaki Y, Fujiuchi S, Fujita Y, Yamazaki Y, Sato M, Yamamoto Y, et al. Increased serum level of vascular endothelial growth factor in Mycobacterium avium complex infection. Respirology. 2006;11:407–13.

    Article  PubMed  Google Scholar 

  30. Christou GA, Tellis KC, Elisaf MC, Tselepis AD, Kiortsis DN. High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment. Hormones (Athens). 2012;11:178–88.

    Article  PubMed  Google Scholar 

  31. Obata Y, Yamada Y, Takahi Y, Baden MY, Saisho K, Tamba S, et al. Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes. Clin Endocrinol (Oxf). 2013;79:204–10.

    Article  CAS  PubMed  Google Scholar 

  32. Laughlin GA, Barrett-Connor E, May S. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes (Lond). 2007;31:457–65.

    Article  CAS  Google Scholar 

  33. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Investig. 2006;116:1784–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Lo MM, Salisbury S, Scherer PE, Furth SL, Warady BA, Mitsnefes MM. Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease. Pediatr Nephrol. 2011;26:2009–17.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This research was supported by grants 2011E3300300, 2012E3301100 and 2013E3301600 from Research of Korea Centers for Disease Control and Prevention, and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611).

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Chonnam National University Medical School, 42 Jebongro, Gwangju, 501-757, Korea

    Ha Yeon Kim, Eun Hui Bae, Seong Kwon Ma & Soo Wan Kim

  2. Department of Internal Medicine, Seoul National University, Seoul, Korea

    Dong Wan Chae & Curie Ahn

  3. Department of Internal Medicine, Severance Hospital, Yonsei University, Seoul, Korea

    Kyu Hun Choi

  4. Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea

    Yong-Soo Kim

  5. Department of Internal Medicine, Eulji General Hospital, Eulji University, Seoul, Korea

    Young-Hwan Hwang

Authors
  1. Ha Yeon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eun Hui Bae
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seong Kwon Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dong Wan Chae
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kyu Hun Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yong-Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Young-Hwan Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Curie Ahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Soo Wan Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Soo Wan Kim.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, H.Y., Bae, E.H., Ma, S.K. et al. Association of serum adiponectin level with albuminuria in chronic kidney disease patients. Clin Exp Nephrol 20, 443–449 (2016). https://doi.org/10.1007/s10157-015-1173-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-015-1173-4

Keywords

Search

Navigation